If you are struggling with depression, our team is here to support you. Despite the many treatments for depression, finding one that works for you can sometimes feel like an uphill battle. While antidepressants are effective for some, about one in three patients do not feel relief with this medication. If you have tried traditional treatments without success, you may be experiencing treatment-resistant depression.
At Shore Clinical TMS and Wellness Center, you can receive expert mental health care that restores your hope for a solution. SPRAVATO is designed specifically for those with treatment-resistant depression. We are here to help you understand your options for symptom management. Let us take a look at what you can expect from SPRAVATO for treatment-resistant depression in Linwood.
Treatment-resistant depression (TRD) is a mental health condition characterized by symptoms of depression that are not adequately alleviated by conventional treatments, such as antidepressants or psychotherapy. Treatment-resistant depression is typically diagnosed after clients have tried two different types of antidepressants without experiencing meaningful symptom relief. Common signs of depression include:
SPRAVATO works differently than traditional medications, and can produce results for Linwood patients with treatment-resistant depression more quickly. Dr. Srisai Gowda will conduct a mental health evaluation to determine your mental health needs and whether this treatment is a good option for you.
SPRAVATO is administered as a nasal spray that is FDA-approved to manage treatment-resistant depression. It is formulated with esketamine, which acts on glutamate receptors in the brain to heal neural connections that regulate mood and emotions. It also boosts neuroplasticity, which is the brain’s ability to adapt and heal itself over time.
SPRAVATO can produce results more quickly than traditional treatments in Linwood, making it a good option for those who need more rapid mental health intervention, such as individuals with treatment-resistant depression. Many patients report meaningful symptom relief within just 24 hours of their first SPRAVATO dose. For those who can tolerate antidepressants, combining this oral medication with SPRAVATO can produce even more transformative and lasting results.
Your SPRAVATO treatments for your TRD will be administered at our Linwood clinic under the careful supervision of one of our certified psychiatry providers. They are administered based on a phase-based dosing schedule that begins with two sessions per week during the first month, then once weekly for an additional month, and then the frequency will gradually decrease based on your response. This schedule is scientifically proven to optimize lasting results.
Throughout each session, we will monitor your mental and physical health through metrics like heart rate, oxygen, and blood pressure to ensure your safety and comfort.
You may experience temporary side effects such as dizziness and increased blood pressure during sessions. Please let us know if you are experiencing any uncomfortable mental or physical symptoms. We also require that you arrange for someone to drive you home after your sessions, as esketamine is considered a sedative and makes you drowsy.
If you are still searching for ways to improve your mental well-being after not having success with traditional treatments, SPRAVATO may restore your hope for long-awaited relief. As the only practice in the state of New Jersey that provides all advanced treatment options for depression under one roof, we are dedicated to finding solutions that work for you. Contact us today to learn more about SPRAVATO for treatment-resistant depression in Linwood and find out if this treatment is right for you.
